Home›People›Sandra Brine
Sandra Brine

Sandra Brine

Founder and CEO at idaptiq

ExecutiveDirector
Updated Nov 4, 2026·Latest SEC filing Nov 2, 2026·Suggest an edit

About Sandra Brine

Sandy Ferber Brine is the founder and CEO of idaptiq. The company makes software that automates biostatistics work for clinical trials.

Before idaptiq, she founded and led Array Biostatistics as CEO for eight years, until Allucent bought it. She then served as President of Biometrics at Allucent. The company site says she has 25 years in the biopharmaceutical industry.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Sandra Brine in the role, so the role may have started earlier or lasted longer.

Idaptiq Trials Inc. Current
Founder and CEO, director
2026 – Present · Presque Isle, MI
idaptiq sells software that automates the biostatistics work behind clinical trial submissions to the FDA and other regulators.
Allucent
President of Biometrics
Array Biostatistics
Founder and CEO

Key Colleagues at Startups

The people Sandra Brine works with at each company, as listed on that company's latest Form D.

Idaptiq Trials Inc. · Form D, Nov 2, 2026
NF
Nathaniel Fox
Co-founder and CTO

Sources

  1. SECIdaptiq Trials Inc. Form D, filed Nov 2, 2026